SEARCH:

News for Food and Drug Administration (FDA)

News > FDA

Listings 301 - 310 of 465:

Scientists Conclude Very Low Risk to Humans from Food Containing Melamine: FDA
There is very low risk to human health from consuming meat from hogs and chickens known to have been fed animal feed supplemented with pet food scraps...

FDA Advises Manufacturers to Test Glycerin for Possible Contamination
he U.S. Food and Drug Administration (FDA) is warning pharmaceutical manufacturers, suppliers, drug repackers, and health professionals who compound m...

FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
Aastrom Biosciences, a regenerative medicine company, announced that the U.S. Food & Drug Administration (FDA) approved the Company's Investigational ...

Genaera Corporation Initiates Human Study of Obesity Compound Trodusquemine
Genaera Corporation announced that it has begun enrolling subjects in the first human clinical study of trodusquemine (MSI-1436) under the Investigati...

Healthcare Providers Direct Partners with NACH to Provide Rapid HIV Testing to Large Patient Populations
Healthcare Providers Direct, an early-stage company focused on the development and distribution of rapid diagnostic tests directly to physicians’ offi...

Indevus Announces FDA Approval Of SUPPRELIN-LA
Indevus Pharmaceuticals announced that SUPPRELIN(R)-LA (histrelin acetate subcutaneous implant) 50mg has been approved by the U.S. Food and Drug Admin...

FDA Approves Oscient Pharmaceuticals' FACTIVE Tablets for Five-Day Treatment of Community-Acquired Pneumonia
The U.S. Food and Drug Administration (FDA) has approved Oscient Pharmaceuticals' (Nasdaq: OSCI) FACTIVE (gemifloxacin mesylate) tablets for the five-...

Connecticut Attorney General Calls For Stronger Warning Labels On Caffeine Pills
Connecticut Attorney General Richard Blumenthal called on the Food and Drug Administration (FDA) and a drug manufacturer to strengthen warning labels ...

FDA Advisory Committee Finds Substantial Evidence to Support Advair 500/50 in Reducing COPD Exacerbations
An Advisory Committee to the U.S. Food and Drug Administration (FDA) unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus(R) 500/50 (flut...

Poniard Pharmaceuticals Announces Treatment Of First Patient With Picoplatin In Pivotal Phase 3 Small Cell Lung Cancer Trial
Poniard Pharmaceuticals, a biopharmaceutical company focused on oncology, announced treatment of the first patient with picoplatin in its pivotal Phas...

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 Next

Get Free Security Resources from Symantec